-
Westlake Chemical Partners Q1 net income $14.2M, up from $4.9M; distribution $0.4714/unit
Net income attributable to Partnership of $14.2M ($0.40/unit) vs $4.9M in Q1 2025.
-
Westlake Chemical Partners Q4 net income $14.5M, coverage ratio 1.13x, distribution $0.4714
Q4 net income $14.5M ($0.41/unit) vs $15.0M in Q4 2024; full year net income $48.7M ($1.38/unit), down from $62.4M.
-
WLKP Q3 net income $14.7M ($0.42/unit); renews ethylene deal through 2027 at same terms
Q3 net income $14.7M ($0.42/unit), down from $18.1M YoY; operating cash flow $105.2M, down $20.9M YoY.
-
Westlake Chemical Partners Q1 net income $4.9M, down from $14.8M YoY; distribution held at $0.4714/unit
Net income attributable to partnership of $4.9M ($0.14/unit) vs Q1 2024 net income of $14.8M.
-
Westlake Chemical Partners Q4 net income $15M flat YoY; full-year net income up 15% to $62.4M
Q4 2024 net income $15.0M ($0.43/unit) vs $14.3M Q4 2023; full-year $62.4M ($1.77/unit) vs $54.3M.
-
Westlake Chemical Partners Q3 2024 net income $18.1M, up 37% YoY; distribution $0.4714/unit
Net income attributable to Partnership $18.1M ($0.51/unit), up from $13.2M in Q3 2023.
-
Westlake Chemical Partners Q2 net income $14.4M ($0.41/unit); distribution declared
Net income $14.4M ($0.41/unit) up from $11.9M YoY; operating cash flow $121.9M, +$23.4M.
-
Westlake Chemical Partners appoints Jean-Marc Gilson CEO; Chao family transitions to chairman roles
James Chao becomes Senior Chairman; Albert Chao becomes Executive Chairman of the General Partner.
-
Westlake Chemical Partners Q4 net income down 15% YoY; coverage ratio falls to 0.94x
Q4 2023 net income $14.3M ($0.41/unit) vs $16.8M in Q4 2022; full year $54.3M vs $64.2M.
-
Westlake Chemical Partners Q2 net income $11.9M ($0.34/unit) down 27% YoY; distribution unchanged
Net income $11.9M ($0.34/unit), down 27% YoY from $16.4M; driven by Calvert City turnaround and higher interest expense.
-
Westlake Chemical Partners Q4 net income $16.8M, down 43% YoY; distribution held at $0.4714/unit
Q4 2022 net income attributable to Partnership $16.8M ($0.48/unit) vs $29.5M in Q4 2021, down on lower buyer deficiency fee and higher interest expense.
-
Westlake Chemical Partners Q3 net income up 16% to $14.8M; declares $0.4714 distribution
Net income attributable to Partnership $14.8M ($0.42/unit) vs $12.8M in Q3 2021, up 16%.
-
Westlake Chemical Partners Q2 net income $16.4M, down 35% YoY; distribution steady at $0.4714
Net income attributable to Partnership $16.4M ($0.47/unit) vs $25.1M in Q2 2021, primarily due to prior-year buyer deficiency fee.
-
Westlake Chemical Partners reports record FY2021 net income $82.5M; Q4 distribution $0.4714/unit
Q4 2021 net income attributable to Partnership $29.5M ($0.84/unit), up from $15.0M in Q4 2020.
-
Westlake Chemical Partners Q3 net income down 31% to $12.8M; distribution steady at $0.4714/unit
Net income attributable to Partnership was $12.8M ($0.36/unit), down from $18.5M in Q3 2020.
-
Westlake Chemical Partners Q2 net income record $25.1M, up 68% YoY; distribution $0.4714/unit
Net income $25.1M ($0.71/unit) vs $14.9M Q2 2020; record quarterly net income.